On August 31, 2023, Ravi Sarin, a member of the Board of Directors of The Oncology Institute, Inc. resigned effective immediately as a director of the Board, including any positions held as a member of any committee of the Board. Mr. Sarin?s resignation was not as a result of any disagreement with the Company on any matter relating to the Company?s operations, policies or practices. Mr. Sarin was a member of the Audit Committee, Compensation Committee and Compliance Committee of the Board.

The Board will consider replacements from the current Board for Mr. Sarin on the aforementioned committees. Following Mr. Sarin?s resignation, the size of the Board is reduced to eight directors.